NCT07212270

Brief Summary

The primary aim of this study is to evaluate the efficacy of intraseptal anesthesia using 0.3 mL of 4% articaine with 1:100,000 epinephrine (4% Ar+Ep) for periodontal flap surgery in patients with periodontitis and for gingivectomy/ gingivoplasty for the excision of hyperplastic gingival enlargements. The secondary aim is to compare clinical anesthetic parameters between the ISA and conventional anesthesia techniques.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Sep 2025Jun 2026

Study Start

First participant enrolled

September 22, 2025

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

September 30, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 8, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

May 5, 2026

Status Verified

May 1, 2026

Enrollment Period

8 months

First QC Date

September 30, 2025

Last Update Submit

May 4, 2026

Conditions

Outcome Measures

Primary Outcomes (7)

  • The anesthetic efficacy

    The absence of pain for two pinprick tests in a row.

    5 min after injection

  • The width of the anesthetic field on the buccal side

    maximal distance between the two painless needle's pricks on the buccal aspect of attached gingiva

    5 min after injection

  • The width of the anesthetic field on oral side

    The maximal distance between the two painless needle's pricks on the oral aspect of the attached gingiva.

    5 min after injection

  • VASa

    The intensity of pain measured on 100mm Visual Analogue Scale, where 0 represented no pain and 100 the worst pain imaginable.

    immediately after anesthetic administration

  • VASi

    The intensity of pain measured on 100mm Visual Analogue Scale, where 0 represented no pain and 100 the worst pain imaginable.

    at the end of the treatment

  • VASp

    The intensity of pain measured on 100mm Visual Analogue Scale, where 0 represented no pain and 100 the worst pain imaginable.

    one day follow-up

  • The duration

    The duration of intervention, measured in minutes.

    form start to finish od intervention

Study Arms (4)

GG test

EXPERIMENTAL

Patient subjected to gingivectomy and gingivoplasty interventions and anesthesia of choice is intraseptal anesthesia.

Procedure: gingivectomy and gingivoplasty

GG control

ACTIVE COMPARATOR

Patient subjected to gingivectomy and gingivoplasty interventions under the local infiltration anesthesia.

Procedure: gingivectomy and gingivoplasty

PF test

EXPERIMENTAL

Patients undergoing periodontal flap surgery under the intraseptal anesthesia.

Procedure: periodontal flap surgery

PF control

ACTIVE COMPARATOR

Patients undergoing periodontal flap surgery under the local infiltration anesthesia.

Procedure: periodontal flap surgery

Interventions

Open flap debridement with intra-sulcular incisions or flaps with para-marginal incisions were performed by lifting the mucoperiosteal flap and debriding the periodontal defect under visual control.

PF controlPF test

surgical methods for the excision of hyperplastically enlarged gingiva.

GG controlGG test

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥18 years good systemic health
  • gingivitis or periodontitis stage II and III
  • at least 20 teeth present.

You may not qualify if:

  • allergy to 4%Ar+Ep
  • pregnant or lactating females
  • medication uptake and diseases affecting the periodontal tissues
  • acute pain, swelling, and presence of gingival lesions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Periodontology and Oral medicine, School of Dental Medicine, University of Belgrade

Belgrade, 11000, Serbia

Location

MeSH Terms

Conditions

PeriodontitisGingivitisPeriodontal Diseases

Interventions

GingivectomyGingivoplasty

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesInfectionsGingival Diseases

Intervention Hierarchy (Ancestors)

Oral Surgical ProceduresSurgical Procedures, OperativeDentistryPeriodontics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
Periodontist do not know the type of anesthesia given by the investigator
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2 parallel groups, each with the experimental and the control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

September 30, 2025

First Posted

October 8, 2025

Study Start

September 22, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

May 5, 2026

Record last verified: 2026-05

Locations